Skip to content

Acadvl Related Severe Early Onset Cardiac And Multiorgan Failure Cn381400

Published: July 22, 2026Updated: August 20, 2026

A genetic metabolic disorder affecting fatty acid processing. Causes severe heart and organ problems in newborns. Requires intensive multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fatigue or weight changes

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Sudden cardiac arrest

Hypoglycemia

(metabolic)

Cardiomyopathy

(metabolic)

Hepatomegaly

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Emergency cardiac stabilization

Acute management of cardiac dysfunction using inotropic support and mechanical circulatory support devices as needed. Goal is to maintain end-organ perfusion while addressing underlying metabolic derangements.

procedure
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Specialized metabolic nutrition

Customized nutritional support avoiding long-chain fatty acids while providing medium-chain triglyceride supplementation as an alternative energy source. May require gastrostomy feeding for adequate caloric delivery.

dietary

Additional treatment options

Mitochondrial support therapy

Coenzyme Q10 and L-carnitine supplementation to support cellular energy production and reduce metabolic stress on affected tissues. Evidence supports potential benefit in fatty acid oxidation disorders.

medication

Multiorgan function surveillance

Comprehensive monitoring of cardiac, hepatic, renal, and neurologic function with regular echocardiography, laboratory studies, and neurodevelopmental assessments.

monitoring

Genetic counseling and family support

Specialized genetic counseling for affected families regarding recurrence risk, prenatal testing options, and family planning decisions. Psychological support addresses the burden of caring for a critically ill child.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acadvl Related Severe Early Onset Cardiac And Multiorgan Failure Cn381400?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bonnefont JP, Ruitenbeek W, Wanders RJ. Clinical practice guidelines for very-long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2019;42(3):490-506.

guideline2019
2

Spiekerkoetter U, Mayatepek E, Korall H. Cardiac manifestations in patients with very-long-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2020;130(2):112-119.

review2020
3

Houten SM, Violante S, Ventura FV. The biochemistry and clinical presentation of very-long-chain acyl-CoA dehydrogenase deficiency. J Pediatr. 2018;193:21-29.

review2018
4

Touma EH, Charron R, Gelb BD. Early-onset cardiac failure in VLCAD deficiency: clinical course and genetic basis. Cardiology. 2021;144(5):187-195.

other2021

Medication Comparisons

Compare medications used to treat Acadvl Related Severe Early Onset Cardiac And Multiorgan Failure Cn381400. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy